DE60322065D1 - Gpi verankertes glykoprotein aca als neuer tumormarker - Google Patents

Gpi verankertes glykoprotein aca als neuer tumormarker

Info

Publication number
DE60322065D1
DE60322065D1 DE60322065T DE60322065T DE60322065D1 DE 60322065 D1 DE60322065 D1 DE 60322065D1 DE 60322065 T DE60322065 T DE 60322065T DE 60322065 T DE60322065 T DE 60322065T DE 60322065 D1 DE60322065 D1 DE 60322065D1
Authority
DE
Germany
Prior art keywords
aca
gpi
relates
anchor
tumor marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322065T
Other languages
English (en)
Inventor
Zorica Becker-Kojic
Peter Terness
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BECKER KOJIC ZORICA
Original Assignee
BECKER KOJIC ZORICA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BECKER KOJIC ZORICA filed Critical BECKER KOJIC ZORICA
Application granted granted Critical
Publication of DE60322065D1 publication Critical patent/DE60322065D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60322065T 2002-08-06 2003-08-06 Gpi verankertes glykoprotein aca als neuer tumormarker Expired - Lifetime DE60322065D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02017524A EP1391463A1 (de) 2002-08-06 2002-08-06 GPI verankertes Glykoprotein ACA als neuer Tumormarker
PCT/EP2003/008711 WO2004014948A2 (en) 2002-08-06 2003-08-06 Gpi anchored glycoprotein aca as a novel tumor marker

Publications (1)

Publication Number Publication Date
DE60322065D1 true DE60322065D1 (de) 2008-08-21

Family

ID=30775786

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322065T Expired - Lifetime DE60322065D1 (de) 2002-08-06 2003-08-06 Gpi verankertes glykoprotein aca als neuer tumormarker

Country Status (9)

Country Link
US (1) US20060276375A1 (de)
EP (2) EP1391463A1 (de)
JP (2) JP2006516087A (de)
AT (1) ATE400585T1 (de)
AU (1) AU2003250217A1 (de)
DE (1) DE60322065D1 (de)
DK (1) DK1527092T3 (de)
ES (1) ES2322349T3 (de)
WO (1) WO2004014948A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2386311T3 (es) * 2004-05-05 2012-08-17 Zorica Becker-Kojic Uso de anticuerpos anti glicoproteína ACA para obtener/mantener células madre pluripotentes no embrionarias
EP2749640A1 (de) 2012-12-27 2014-07-02 Zorica Becker-Kojic Verfahren zur Herstellung ektodermaler, mesodermaler und endodermaler Zellen sowie pluripotenter Stammzellen, hämatopoetischer Stammzellen, Seitenpopulationszellen und mesenchymalen Stammzellen sowie ein Verfahren zur Entdifferenzierung peripherer Blutzellen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies

Also Published As

Publication number Publication date
EP1391463A1 (de) 2004-02-25
WO2004014948A2 (en) 2004-02-19
WO2004014948A3 (en) 2004-04-15
EP1527092A2 (de) 2005-05-04
JP2010154859A (ja) 2010-07-15
ATE400585T1 (de) 2008-07-15
ES2322349T3 (es) 2009-06-19
EP1527092B1 (de) 2008-07-09
DK1527092T3 (da) 2008-11-10
US20060276375A1 (en) 2006-12-07
JP2006516087A (ja) 2006-06-22
JP5486945B2 (ja) 2014-05-07
AU2003250217A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
JP6207509B2 (ja) 固形腫瘍を治療するためのｆａｐ活性化プロテアソーム阻害剤
Meng et al. Remote effects in macrolide formation through ring-forming olefin metathesis: an application to the synthesis of fully active epothilone congeners
White et al. Total Synthesis of Epothilone B, Epothilone D, and cis-and trans-9, 10-Dehydroepothilone D
CN104945401B (zh) Ip化合物及它们在治疗中的应用
MA29649B1 (fr) Nouveaux derives de 2,4- dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
ATE54154T1 (de) Retro-inverse analoga des bradykininpotentialisierenden peptids bpp-5a und verfahren zu ihrer herstellung.
MXPA04004882A (es) Metodo para la identificacion de enzimas que tienen como objetivo tumores.
KR20150023252A (ko) 5-[[4-[[모르폴린-2-일]메틸아미노]-5-(트리플루오로메틸)-2-피리딜]아미노]피라진-2-카보니트릴 및 그의 치료적 용도
TR200003159T2 (tr) Antipicornaviral bileşikler, hazırlanışları ve kullanımları
Williams et al. Spirastrellolides C to G: Macrolides obtained from the marine sponge Spirastrella coccinea
CY1110185T1 (el) Τροποποιημενη πρωτεϊνη vp1-καψιδιου του παρβοϊου β19
JP2017522296A (ja) 活性化可能な水溶性の分子プローブ、その合成のための中間体、および関連する検出方法
Regueiro-Ren et al. SAR and pH stability of cyano-substituted epothilones
Zask et al. Synthesis and Biological Activity of Analogues of the Antimicrotubule Agent N, β, β-Trimethyl-l-phenylalanyl-N-[(1 S, 2 E)-3-carboxy-1-isopropylbut-2-enyl]-N 1, 3-dimethyl-l-valinamide (HTI-286)
Robl et al. Vasopeptidase inhibitors: incorporation of geminal and spirocyclic substituted azepinones in mercaptoacyl dipeptides
US9814787B2 (en) Luciferin amides
Tsakos et al. The rakicidin family of anticancer natural products–synthetic strategies towards a new class of hypoxia-selective cytotoxins
EP3168288B1 (de) Fluoreszierende sonde zum nachweis von dipeptidylpeptidase iv
CN1449412A (zh) Dds化合物及其制备方法
DE60322065D1 (de) Gpi verankertes glykoprotein aca als neuer tumormarker
NO20054631D0 (no) Antistoff mot tumorspesifikt antigen som mal
Sanchez et al. Total synthesis of amphidinolide K, a macrolide that stabilizes F-actin
US11833137B2 (en) Substituted chromenones, IRE1 inhibitors, and methods of using same
Haeussler et al. Fluorescently labeled amino acids as building blocks for bioactive molecules
DK1142905T3 (da) Hidtil ukendt depsipeptidforbindelse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition